These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24018901)

  • 1. Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.
    Ishikawa C; Tanaka J; Katano H; Senba M; Mori N
    Mar Drugs; 2013 Sep; 11(9):3410-24. PubMed ID: 24018901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Ishikawa C; Mori N
    Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
    Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
    Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
    Ueno M; Kariya R; Sittithumcharee G; Okada S
    Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
    Ishikawa C; Mori N
    Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.
    Tsumuraya T; Ishikawa C; Machijima Y; Nakachi S; Senba M; Tanaka J; Mori N
    Biochem Pharmacol; 2011 Mar; 81(6):713-22. PubMed ID: 21219881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways.
    Granato M; Rizzello C; Gilardini Montani MS; Cuomo L; Vitillo M; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
    J Nutr Biochem; 2017 Mar; 41():124-136. PubMed ID: 28092744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
    Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
    Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma.
    Kojima Y; Hayakawa F; Morishita T; Sugimoto K; Minamikawa Y; Iwase M; Yamamoto H; Hirano D; Imoto N; Shimada K; Okada S; Kiyoi H
    Pharmacol Res; 2017 Jun; 120():242-251. PubMed ID: 28396094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
    Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
    PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
    Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
    Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.